Related Experiment Video
Updated: Apr 20, 2026

05:19
Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
1.8K
Are entry criteria for cataract surgery justified?
Daniel Böhringer1, Werner Vach2, Kai Hagenlocher1
1Eye Center, University Hospital, Freiburg, Germany.
Plos One
|November 18, 2014
Summary
The German Ophthalmological Society
Area of Science:
- Ophthalmology
- Surgical Training
- Patient Safety
Background:
- The German Ophthalmological Society (GOS) proposed 300 cataract surgeries as a benchmark for surgical training.
- Assessing surgical experience against complication rates is crucial for refining training standards.
Purpose of the Study:
- To evaluate the appropriateness of the GOS recommendation of 300 cataract surgeries by correlating surgical experience with posterior capsule rupture (PCR) risk.
- To analyze the learning curve for cataract surgery in relation to PCR incidence.
Main Methods:
- Retrospective analysis of 5475 cataract surgeries performed at University Eye Hospital Freiburg (2008-2012).
- Surgeons' procedures were ranked sequentially; surgeries were classified as low- vs. high-risk for PCR.
- Multifactorial logistic regression and learning curve visualization were employed.
Main Results:
- The odds of PCR were 3.8 times higher during the first 300 surgeries ('learning-mode') compared to later procedures (p<0.0001).
- Low-risk cases significantly reduced PCR rates (p<0.0001).
- The PCR rate in low-risk cases decreased from 4% to 0.5% after 1500 surgeries, then stabilized around 1%.
Conclusions:
- The learning curve for PCR is relatively flat, supporting the GOS criterion of 300 surgeries.
- The GOS recommendation of 300 cataract surgeries appears justified based on this analysis.
- Selecting low-risk patients for trainees can mitigate PCR rates during surgical education.
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Photoreceptors and Visual Pathways
11.3K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.3K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

